MMNFQ (MedMen Enterprises) Effective Interest Rate on Debt %: 12.42% (As of Mar. 2023)


What is MedMen Enterprises Effective Interest Rate on Debt %?

MedMen Enterprises MMNFQ -90.00% Effective Interest Rate on Debt % is 12.42% as of Mar. 2023.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. MedMen Enterprises's annualized positive value of Interest Expense for the quarter that ended in Mar. 2023 was $46.6 Mil. MedMen Enterprises's average total debt for the quarter that ended in Mar. 2023 was $375.0 Mil. Therefore, MedMen Enterprises's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2023 was 12.42%.

MedMen Enterprises  (OTCPK:MMNFQ) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

MedMen Enterprises Effective Interest Rate on Debt % Related Terms

MedMen Enterprises Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for MedMen Enterprises's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMen Enterprises Effective Interest Rate on Debt % Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.85 12.47 9.78 10.87 10.18

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.66 4.71 12.15 12.12 12.42

MMNFQ vs ZTS, VTRS, NBIX: Effective Interest Rate on Debt % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMen Enterprises Effective Interest Rate on Debt % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's Effective Interest Rate on Debt % falls into.


MedMen Enterprises Effective Interest Rate on Debt % Calculation

MedMen Enterprises's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Jun. 2022 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Jun. 2021 )+Total Debt  (A: Jun. 2022 ))/ count )
=-1  *  -43.073/( (450.299+395.839)/ 2 )
=-1  *  -43.073/423.069
=10.18 %

where

Total Debt  (A: Jun. 2021 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=338.523 + 111.776
=450.299

Total Debt  (A: Jun. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=277.023 + 118.816
=395.839

MedMen Enterprises's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2022 )+Total Debt  (Q: Mar. 2023 ))/ count )
=-1  *  -46.56/( (370.803+379.184)/ 2 )
=-1  *  -46.56/374.9935
=12.42 %

where

Total Debt  (Q: Dec. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=288.317 + 82.486
=370.803

Total Debt  (Q: Mar. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=67.414 + 311.77
=379.184

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 12.42% mean?
MedMen Enterprises (MMNFQ) has a Effective Interest Rate on Debt % of 12.42% as of Mar. 2023. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on MedMen Enterprises and its competitors.
Is MedMen Enterprises' Effective Interest Rate on Debt % too high?
MedMen Enterprises' current Effective Interest Rate on Debt % is 12.42%.
How does MedMen Enterprises' Effective Interest Rate on Debt % compare to ZTS and VTRS?
MedMen Enterprises' Effective Interest Rate on Debt % of 12.42% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Drug Manufacturers company?
A good Effective Interest Rate on Debt % depends on the Drug Manufacturers industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on MedMen Enterprises and its competitors. MedMen Enterprises's current Effective Interest Rate on Debt % is 12.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMen Enterprises stock overvalued right now?
MedMen Enterprises (MMNFQ) has a current Effective Interest Rate on Debt % of 12.42%. The current Effective Interest Rate on Debt % is 12.42%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For MedMen Enterprises (MMNFQ), the current Effective Interest Rate on Debt % is 12.42% as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMen Enterprises Business Description

Address 8740 S Sepulveda Boulevard, Suite 105, Los Angeles, CA, USA, 90045
MedMen Enterprises Inc is a American cannabis company dedicated to improving life with Cannabis for All. With operations across the United States in California, Nevada, Illinois, Arizona, Massachusetts, and New York, the company has MedMen and LuxLyte brands offering cannabis in consumer-preferred product forms for medical and recreational use. It produces and curates the consumer product assortment for retail operations in its local communities, and drives consumer loyalty with service and engaging in-store experience, combined with reward, delivery, and e-commerce programs.